Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The effect of PNPO-OE in Multiple myeloma cells ARP1 and H929

ABSTRACT: The effect of PNPO-OE in Multiple myeloma cells ARP1 and H929

PROVIDER: PRJNA961044 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

The effect of PNPO-OE in Multiple myeloma cells ARP1 and H929

Project description:To explore the function of PNPO, we constructed ARP1 and H929 pTSB-EV/PNPO-OE cell lines via lentivirus packaging. We found different genes change between EV and OE cells.

2025-02-12 | GSE230387 | GEO

Multiple myeloma

Project description:Multiple myeloma

| PRJNA515992 | ENA

Transcription profiling of three human multiple myeloma cell lines treated with 5-aza-2-deoxycytidine and/or trichostatin A

Project description:To identify epigenetically silenced genes in multiple myeloma (MM) cell lines and to determine the effects of 5-aza-2-deoxycytidine and trichostatin A on gene expression. We treated 3 multiple myeloma cell lines (MM1, NCI-H929, U266) with 5-aza-2-deoxycytidine and/or trichostatin A.

2008-02-01 | E-MEXP-1269 | biostudies-arrayexpress

Control of Autophagic Cell Death by Caspase-10 in Multiple Myeloma

Project description:We performed a loss-of-function, RNA interference screen to define new therapeutic targets in multiple myeloma, a genetically diverse plasma cell malignancy. Unexpectedly, we discovered that all myeloma lines require caspase-10 for survival, irrespective of their genetic abnormalities. The transcription factor IRF4 induces both caspase-10 and its associated protein cFLIPL in myeloma, generating a protease that does not induce apoptosis but rather blocks an autophagy-dependent cell death pathway. Caspase-10 inhibits autophagy by cleaving the BCL2-interacting protein BCLAF1, itself a strong inducer of autophagy that acts by displacing beclin-1 from BCL2. While myeloma cells require a basal level of autophagy for survival, caspase-10 tempers this response to avoid cell death. Drugs that disrupt this vital balance may have therapeutic potential in myeloma. To generate a gene expression signature of caspase 10 signaling in multiple myeloma, cell lines (SKMM1 n=16, KMS12 n=8 and H929 n=12) were transduced with retroviral vectors expressing either shCasp10-2 or shCasp10-3. Similarly, lymphoma cell lines (OCI-Ly7 n=2 and OCI-Ly19 n=2) were transduced and used as a control. Following puromycin selection, shRNA expression was induced for 24 to 120 hours and gene expression was measured, comparing uninduced (Cy3) to induced (Cy5) cells, using lymphochip microarrays. Biological repeats were performed of H929 and SKMM1 samples.

2013-03-13 | E-GEOD-43878 | biostudies-arrayexpress

Transcriptome analysis of RFWD2 overexpression (OE) and control (WT) in Multiple myeloma

Project description:Transcriptome analysis of RFWD2 overexpression (OE) and control (WT) in Multiple myeloma

| PRJNA627911 | ENA

Multiple Myeloma cells

Project description:Multiple Myeloma cells

| PRJNA800411 | ENA

RNA-sequencing analysis of non silencing or ILF2 shRNA-transduced H929 cells

Project description:To understand whether ILF2 is required to ensure the alternative splicing and processing of specific pre-mRNAs in Multiple Myeloma (MM) in physiological conditions, we performed RNA sequencing (RNA-Seq) analysis of ILF2- and non-silencing shRNA transduced H929 cells.

2017-05-23 | GSE97323 | GEO

RNA-seq analysis after dBRD9-A treatment in human multiple myeloma cell line OPM2 and H929

Project description:RNA-seq analysis after dBRD9-A treatment in human multiple myeloma cell line OPM2 and H929

| PRJNA810495 | ENA

Transcriptome analysis of G6PD overexpression(OE) and wildtype(WT) cells in Multiple Myeloma

Project description:Transcriptome analysis of G6PD overexpression(OE) and wildtype(WT) cells in Multiple Myeloma

| PRJNA722941 | ENA

RNA-seq of H929 cells treated with Solamargine against untreated controls

Project description:To investigate the effects of Solamargine (SM) on multiple myeloma (MM), here we employed RNA-sequencing experiment to explore the transcriptomic response of SM in H929 cells. RNA was extracted from two groups of samples, 3 samples of each, processing as follows: one was treated with a certain volume of SM, and the another was blank control. A total of 6 paired-end RNA-seq datasets were obtained eventually.

2021-08-23 | E-MTAB-10816 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data